Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal

In this randomized clinical trial that included 412 adults, 90-day mortality was 41.5% in the lower tidal volume with extracorporeal carbon dioxide removal group and 39.5% in the standard care group, a difference that was not statistically significant.

James J. McNamee, MB, ChB, and Daniel McCauley, MD, of the Wellcome Wolfson Institute for Experimental Medicine in Belfast, United Kingdom present findings from the REST Randomized Clinical Trial at a Critical Care Reviews livestream presentation on January 21, 2022.

An oral editorial from Eddy Fan, MD, PhD of Toronto General Hospital in Ontario, Canada and panel discussion follow.

Click https://ja.ma/3ufu4gA for full trial details.

#ISICEM21

You May Also Like